SEC Form 4 · accession 0001127602-18-007066
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 15, 2018
Accepted (ET)
Feb 20, 2018 · 2:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2018 | S | 46 | $107.50 | D | 29,954 | I | 2017 GRAT |
| Common Stock | holding | — | — | — | 292,621 | D | ||
| Common StockF2 | holding | — | — | — | 10,208 | I | 2016 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On 8/31/2017, the reporting person contributed 30,000 shares of CRL common stock to a grantor retained annuity trust for the benefit of himself and his 2 adult children.
- F2On 8/31/2016, the reporting person contributed 10,208 shares of CRL common stock to a grantor retained annuity trust for the benefit of himself and his 2 adult children.